Evolving Insights Into the Optimal Timing of Antiretroviral Therapy
 |
|
Paul E. Sax, MD, reviews the optimal timing of antiretroviral therapy in response to revised recommendations issued by the Department of Health and Human Services.
Format: Microsoft PowerPoint (.ppt) | File size: 1,587 KB | Date posted: 4/23/2008
Slide topics include:
|
Browse Slides by Date - Descending
Expert Viewpoint: Aging in the HIV-Infected Patient
 |
|
HIV-infected patients are living longer than ever expected. Review data related to the management of aging HIV-infected patients in this resource accompanying the Stay Tuned program.
Format: Microsoft PowerPoint (.ppt) | File size: 512 KB | Date posted: 4/4/2008
Slide topics include:
|
New This Month: New Drugs in Clinical Practice: Update from Boston
 |
|
Review updated data involving new antiretroviral agents presented at the 2008 Conference at Retroviruses and Opportunistic Infections in this resource for the program Stay Tuned.
Format: Microsoft PowerPoint (.ppt) | File size: 483 KB | Date posted: 4/4/2008
Slide topics include:
|
Answering the Questions: Practical Management Strategies for Cardiovascular Risk in HIV
 |
|
Pablo Tebas, MD reviews the key data pertaining to frequently asked questions about diagnosing and managing cardiovascular risks in HIV-infected patients.
Format: Microsoft PowerPoint (.ppt) | File size: 1,358 KB | Date posted: 3/13/2008
Slide topics include:
|
HIV/AIDS Update From Boston
 |
|
*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.
Comprehensive slideset of the most clinically relevant data from the 2008 Conference on Retroviruses and Opportunistic Infections held in Boston, Massachusetts.
Format: Microsoft PowerPoint (.ppt) | File size: 1,463 KB | Date posted: 3/11/2008
Slide topics include:
|
HSV-2 Suppression by Valacyclovir Reduces Plasma and Rectal HIV-1 RNA Levels in Coinfected Men
 |
|
Twice-daily valacyclovir administration was associated with significant reductions in HIV-1 RNA levels in both plasma and rectal secretions in 20 HIV-1/HSV-2 coinfected men who have sex with men.
Format: Microsoft PowerPoint (.ppt) | File size: 218 KB | Date posted: 3/10/2008
Slide topics include:
|
Resistance Mutations in Treatment-Experienced Patients Failing Darunavir/Ritonavir and Factors Associated With Their Emergence
 |
|
In this retrospective analysis, the authors noted the emergence of recognized darunavir resistance mutations in patients with treatment failure on a darunavir/ritonavir-containing regimen and identified 3 factors associated with their emergence.
Format: Microsoft PowerPoint (.ppt) | File size: 254 KB | Date posted: 3/7/2008
Slide topics include:
|
Extensive Virologic Failure on First 3 Antiretroviral Classes Becoming Rarer in UK Collaborative HIV Cohort
 |
|
Estimated risk of extensive triple-class failure was < 10% after 10 years of therapy, and many patients with such failure were still able to achieve undetectable HIV-1 RNA levels subsequently.
Format: Microsoft PowerPoint (.ppt) | File size: 240 KB | Date posted: 3/5/2008
Slide topics include:
|
Progression to Metabolic Syndrome During First-Line Antiretroviral Therapy Increased Risk of Cardiovascular Disease and Diabetes in INITIO Trial Participants
 |
|
In antiretroviral-naive HIV-infected patients, progression to metabolic syndrome during antiretroviral therapy was independently associated with increased risk of type 2 diabetes and cardiovascular disease.
Format: Microsoft PowerPoint (.ppt) | File size: 253 KB | Date posted: 3/4/2008
Slide topics include:
|
HIV-Infected Blacks Disproportionately Burdened With Chronic Kidney Disease, Even in the Current HAART Era
 |
|
Although the disproportionately high incidence of chronic kidney disease in blacks has decreased in recent years, its prevalence has increased and may be due to increased longevity with HAART.
Format: Microsoft PowerPoint (.ppt) | File size: 245 KB | Date posted: 3/4/2008
Slide topics include:
|
Weekly Alendronate Safe and Effective at Increasing Bone Mineral Density in HIV-Infected Individuals on Antiretroviral Therapy
 |
|
In a randomized ACTG study, alendronate combined with vitamin D and calcium was more effective at increasing bone mineral density in HIV-infected patients vs vitamin D and calcium alone.
Format: Microsoft PowerPoint (.ppt) | File size: 233 KB | Date posted: 3/4/2008
Slide topics include:
|
|
Use the following filters to quickly browse and download slides for your talks
Browse slides by:
All Slides by Date (259)
Program Type
Topic
Featured Content
Read Case Vignettes and then download or listen to a slide presentation.
Capsule Summaries and Expert Highlights on the key studies. Coming soon: Expert Analyses and slides.
Expert faculty members discuss the latest journal articles important for clinical practice.
|
|